Absci

Absci is unlocking the potential of next-generation biologics by harnessing deep learning AI and synthetic biology to explore a vast therapeutic sequence space inaccessible to conventional discovery methods.

Landos Biopharma

Landos Biopharma Inc is a clinical-stage company focused on the discovery and development of oral therapeutics for patients with autoimmune diseases.

Pipeline Therapeutics

Pipeline Therapeutics is focused on  developing first-in-class molecules for neuroregeneration, including synaptogenesis, remyelination and axonal repair.

Ribbon Biolabs

Ribbon Biolabs is a synthetic biology company advancing a new technology for the automated synthesis of long DNA molecules to enable innovation in the life sciences.

Crown Bioscience

CrownBio is helping provide clarity of action in the fight against cancer and diabetes. Acquired by JSR Life Sciences

ACQUIRED

Crown_Bioscience_Logo_-_TEAL.jpg

Tangible Science

Tangible Science is a developer of contact lenses designed to reduce lens discomfort in dry eye diseases. Tangible's technology has the potential to be used from consumer contact lens to smart contact lens.

X-Vax

X-VAX is on a quest to defeat herpes by harnessing the power of antibodies that mediate the killing of infected cells.

Medeon

Medeon designs, develops, and manufactures high-value, high-impact medical device solutions that will transform healthcare.

IPO

Totient Bio

Totient is an AI-driven biotechnology company leveraging tertiary lymphoid structures (TLSs) to identify novel tissue-specific antigens and develop matching high-affinity antibody therapeutics. Acquired by Absci

ACQUIRED

Ausnutria

Ausnutria is a global dutch company specializing in infant care products from new infant formulas and probiotics. Acquired by Yili

ACQUIRED

Lumosa Therapeutics

Lumosa Therapeutics is a clinical-stage pharmaceutical company developing novel therapies and solutions for neurological and oncological diseases

Lumosa.jpg

IPO

TOT Biopharm

TOT Biopharm is dedicated to developing innovative oncology drugs.

tot-biopharm.jpg

IPO

* Investments made prior to Helicase Venture spinout